SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-23-027028
Filing Date
2023-05-26
Accepted
2023-05-26 17:00:58
Documents
6
Period of Report
2023-06-28

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A ny20009150x2_def14a.htm DEF 14A 572080
2 logo_neurobo.jpg GRAPHIC 50705
3 ny20009150x2_barchart01.jpg GRAPHIC 152665
4 ny20009150x2_barchart02.jpg GRAPHIC 87321
5 ny20009150x2_pc1.jpg GRAPHIC 521595
6 ny20009150x2_pc2.jpg GRAPHIC 452335
  Complete submission text file 0001140361-23-027028.txt   2313675
Mailing Address 200 BERKELEY ST. FL 19 BOSTON MA 02116
Business Address 200 BERKELEY ST. FL 19 BOSTON MA 02116 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Filer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37809 | Film No.: 23970048
SIC: 2834 Pharmaceutical Preparations